Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Marinus Pharmaceuticals
Marinus Pharmaceuticals
(MRNS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ztalmy
Ganaxolone
2022-06-01
2026-2037
Infantile spasms
,
Seizures
,
Epileptic syndromes
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ganaxolone
pregnancy complications
,
postpartum depression
,
puerperal disorders
,
depression
,
mood disorders
,
mental disorders
,
depressive disorder
,
behavioral symptoms
,
partial epilepsies
,
spasm
,
infantile spasms
,
postpartum period
,
fragile x syndrome
,
syndrome
,
post-traumatic stress disorders
,
traumatic stress disorders
,
complex partial epilepsy
,
muscle cramp
,
epilepsy
,
status epilepticus
,
tuberous sclerosis
,
sclerosis
,
seizures
,
drug resistant epilepsy
Alfacalcidol
dermatomyositis
,
ulcerative colitis
,
colitis
,
ulcer
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
neoplasm metastasis
,
chronic renal insufficiency
,
left ventricular hypertrophy
,
kidney diseases
,
cardiomegaly
,
hypertrophy
Lotamilast
healthy volunteers/patients
,
fibrosis
,
cholangitis
,
liver cirrhosis
,
biliary liver cirrhosis
,
dyslipidemias
,
hyperlipidemias
,
macular edema
,
retinal diseases
,
diabetic retinopathy
,
hypercholesterolemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
Remetinostat
healthy volunteers/patients
,
fibrosis
,
cholangitis
,
liver cirrhosis
,
biliary liver cirrhosis
,
dyslipidemias
,
hyperlipidemias
,
macular edema
,
retinal diseases
,
diabetic retinopathy
,
hypercholesterolemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
Sepranolone
complex partial epilepsy
Usistapide
healthy volunteers/patients
,
fibrosis
,
cholangitis
,
liver cirrhosis
,
biliary liver cirrhosis
,
dyslipidemias
,
hyperlipidemias
,
macular edema
,
retinal diseases
,
diabetic retinopathy
,
hypercholesterolemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use